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Abstract
Red blood cell (RBC) traits are routinely measured in clinical practice as important markers
of health. Deviations from the physiological ranges are usually a sign of disease, although
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Data Availability Statement: Summary statistics for
all SNPs used in the analysis is available to
researchers upon request, subject to approval. Data
request form can be obtained by emailing Tina Shah
at t.shah@ucl.ac.uk. Data access arrangements for
individual contributing studies are as follows:
1958BC: The 1958 birth cohort data can be accessed
via the UK Data Service (http://ukdataservice.ac.uk/).
BRHS: The collection and management of data over
the last 34 years of the BRHS has been made
possible through grant funding from UK government
agencies and charities. We welcome proposals for
variation between healthy individuals also occurs, at least partly due to genetic factors.
Recent large scale genetic studies identified loci associated with one or more of these traits;
further characterization of known loci and identification of new loci is necessary to better
understand their role in health and disease and to identify potential molecular mechanisms.
We performed meta-analysis of Metabochip association results for six RBC traits—hemo-
globin concentration (Hb), hematocrit (Hct), mean corpuscular hemoglobin (MCH), mean
corpuscular hemoglobin concentration (MCHC), mean corpuscular volume (MCV) and red
blood cell count (RCC)—in 11 093 Europeans from seven studies of the UCL-LSHTM-Edin-
burgh-Bristol (UCLEB) Consortium. We identified 394 non-overlapping SNPs in five loci at
genome-wide significance: 6p22.1-6p21.33 (with HFE among others), 6q23.2 (with HBS1L
among others), 6q23.3 (contains no genes), 9q34.3 (only ABO gene) and 22q13.1 (with
TMPRSS6 among others), replicating previous findings of association with RBC traits at
these loci and extending them by imputation to 1000 Genomes. We further characterized
associations between ABO SNPs and three traits: hemoglobin, hematocrit and red blood
cell count, replicating them in an independent cohort. Conditional analyses indicated the
independent association of each of these traits with ABO SNPs and a role for blood group O
in mediating the association. The 15 most significant RBC-associated ABO SNPs were also
associated with five cardiometabolic traits, with discordance in the direction of effect
between groups of traits, suggesting that ABOmay act through more than one mechanism
to influence cardiometabolic risk.
Introduction
Red blood cell (RBC) traits are routinely measured in clinical practice. These traits, hemoglobin
concentration (Hb), hematocrit (Hct), mean corpuscular hemoglobin (MCH), mean corpuscu-
lar hemoglobin concentration (MCHC), mean corpuscular volume (MCV) and red blood cell
count (RCC) are tightly regulated so that deviations from the physiological ranges are usually a
sign of disease, such as hematological, infectious and immune disorders and cancer. Therefore,
they serve as markers not only of specific hematological conditions but also of the general
health of an individual. However, physiological values for the traits also vary between healthy
individuals and between different ethnic groups, at least in part due to genetic factors [1–13].
Heritability varies between the different RBC traits, with estimates ranging from 40–80% for
Hb and RCC, although values as low as 14% for MCH and as high as 96% for MCV have been
reported [14–17]. Only a few large scale genetic association studies of RBC traits have been per-
formed to date, the latest one identifying 75 loci potentially influencing one or more of these
traits [13]. The largest studies were of Caucasian/European cohorts, followed by studies of Afri-
can Americans and Asians, with several of the RBC-associated loci consistently identified
across different ethnic groups. The recent use of large scale meta-analyses has accelerated the
detection of loci and has emphasized the need for additional studies to identify still undetected
contributors to the underlying genetic basis of these traits [1–13]; reviewed in [18, 19]. Further
characterization of known loci is equally important in order to better understand their roles in
erythropoiesis, susceptibility to and development of different disorders and their impact on the
clinical characteristics and prognosis in those disorders [18–20].
In this study, RBC traits were associated with five loci, including 11 new SNPs for ABO (the
gene encoding ABO blood group), further refining these associations. Conditional analyses
Association between ABO SNPs and RBC Traits
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collaborative projects and data sharing (http://www.
ucl.ac.uk/pcph/research-groups-themes/brhs-pub).
For general data sharing enquiries, please contact
Lucy Lennon (l.lennon@ucl.ac.uk). BWHHS: All
BWHHS data collected is held by the research
team based at London School of Hygiene and
Tropical Medicine, for ongoing analysis. If you
would like to collaborate with the BWHHS team,
contact the study coordinator, Antoinette Amuzu
(antoinette.amuzu@lshtm.ac.uk) Data and biological
samples provided to the collaborators can only be
used for the purposes originally stated and must not
be used in any other way without re-application to the
BWHHS team. No data should be passed on to any
third party unless they were specified in the original
application. CaPS: Data used for the Caerphilly
Prospective study (CaPS) was made available by the
CaPS access committee. More information about its
managed access procedure is available on the study
website (http://www.bris.ac.uk/social-community-
medicine/projects/caerphilly/collaboration/). CoLaus:
Data from the CoLaus/PsyCoLaus study can be
requested according to the procedure described on
the CoLaus website (http://www.colaus.ch/en/cls_
home/cls_pro_home/cls-research-3.htm). ELSA:
ELSA data are made available through the ESDS
website (http://www.elsa-project.ac.uk/availableData).
EAS and ET2DS: Edinburgh Artery Study and
Edinburgh Type 2 Diabetes Study data are
available to researchers upon request, subject to
approval by the data sharing committee. Data request
forms can be obtained by emailing Stela McLachlan
(stela.mclachlan@ed.ac.uk). MRC NSHD: The NSHD
data are made available to researchers who submit
data requests (mrclha.swiftinfo@ucl.ac.uk). More
information is available in the full policy documents
(http://www.nshd.mrc.ac.uk/data.aspx). Managed
access is in place for this study to ensure that use of
the data are within the bounds of consent given
previously by participants, and to safeguard any
potential threat to anonymity since the participants
are all born in the same week. Whitehall II: Data from
the Whitehall II study are made publicly available as
described in the Whitehall II data sharing policy
(https://www.ucl.ac.uk/whitehallII/data-sharing).
Funding: UCLEB: This work was supported by a
British Heart Foundation Programme Grant (RG/10/
12/28456). Individual studies were supported as
follows. 1958BC: DNA collection of the 1958 birth
cohort was funded by the UK Medical Research
Council (G0000934); and the Wellcome Trust (Grant
068545/Z/02). Genotyping was supported by a
contract from the European Commission Framework
Programme 6 (018996); and grants from the French
Ministry of Research. BRHS: The authors
acknowledge the British Regional Heart Study team
for data collection. The British Regional Heart study is
point to the role of ABO SNPs predicting blood group O in the association with Hb, Hct and
RCC and to the independent association of all three traits with the ABO locus. ABO is a highly
pleiotropic locus; direct comparison of results for the 15 most significant RBC-associated ABO
SNPs versus additional cardiometabolic traits showed that RBC (Hct, Hb, RCC) and liver
(logALP) traits exhibited a negative direction of effect whereas some lipid (LDL, TC) and coag-
ulation factor traits (logVWF, FVIII) had a positive effect, indicating the wide influence of the
ABO locus upon cardiometabolic risk.
Results
Meta-analysis in the UCLEB consortium
The study characteristics are given in Table 1. The analysis was done on ~4.2 million genotyped
and imputed SNPs. An identical analysis was performed for each study and trait, accounting
for the covariates available for that specific study, before combining the results by meta-analy-
sis. Genomic-control inflation factors (λGC) varied between 0.987 for Hb in MRC NSHD to
1.041 for RCC in BWHHS in individual studies; these were used to correct the test statistics in
the meta-analysis (S2 Table). Manhattan plots for the meta-analysis of each trait are shown in
S2 Fig. The corresponding Q-Q plots are shown in S3 Fig.
The 736 statistically significant single SNP-trait associations are listed in S3 Table. In total,
there were 394 non-overlapping SNPs in five loci which reached the genome-wide significance
threshold of 5×10−8 used in this study (116 SNPs associated with Hb in three loci; 15 with Hct
in one locus; 371 with MCH in three loci; six with MCHC in one locus; 188 with MCV in four
loci; and 40 with RCC in two loci). 338 of these SNPs (86%) were significantly associated with
more than one RBC trait. The five loci with SNPs reaching statistical significance were: 6p22.1-
6p21.33 (locus includes HFE as a primary candidate gene), 6q23.2 (includesHBS1L gene
among others), 6q23.3 (locus does not contain any genes), 9q34.3 (includes only the ABO
gene) and 22q13.1 (includes the TMPRSS6 gene among others). Overlap of the significant loci
for all six RBC traits is shown in S4 Fig.
The 6p22.1-6p21.33 locus includes 181 genes over ~2.3 Mb and was significantly associated
with Hb, MCH and MCV. The lead SNP (with the lowest P value) for all three traits was
rs80215559 in SLC17A2 gene (P = 8.90×10−14, P = 2.42×10−21 and P = 1.85×10−15, respec-
tively). However, theHFE C282Y functional variant has an extended founder haplotype, there-
fore, HFE is considered to be the primary candidate gene in this locus, previously associated
with all three RBC traits [3–9, 12, 13].
MCH, MCV and RCC were significantly associated with SNPs in the 6q23.2 locus, which is
approximately 272 Kb in size and contains two genes, one pseudogene and a microRNA
(ALDH8A1, HBS1L,MEMO1P2 andMIR3662, respectively). Lead SNPs in this locus were
rs34164109 for MCH (P = 4.52×10−17), rs35959442 for MCV (P = 2.44×10−15) and rs35786788
for RCC (P = 2.47×10−19). One of the genes in this locus (HBS1L) has been repeatedly reported
to be associated with all three traits as part of theHBS1L-MYB region [5–9, 11–13].
The signal at 6q23.3 had only two SNPs reaching the significance threshold, (rs592423 and
rs590856) and the lead association for both was with MCV (P = 1.90×10−8 and P = 2.45×10−8,
respectively). Both SNPs were also associated with MCH and a further 23 SNPs were associated
with MCV at the suggestive threshold of statistical significance. These findings confirm the previ-
ous association of this locus with MCH andMCV [6, 7, 9, 13]. There are no known genes in this
locus, however the closely located CITED2 has been reported as a potential candidate gene.
The 9q34.3 locus contains only the ABO gene and is approximately 16 Kb in size. SNPs in
this locus were associated with Hb, Hct and RCC. rs507666 was the lead SNP for Hb
(P = 1.84×10−10), rs8176643 for Hct (P = 9.64×10−12) and rs8176685 for RCC (P = 1.98×10−8).
Association between ABO SNPs and RBC Traits
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supported by a British Heart Foundation grants
(RG/08/013/25942, RG/13/16/30528). The British
Heart Foundation had no role in the design and
conduct of the study; collection, management,
analysis, and interpretation of the data; preparation,
review, or approval of the manuscript; and decision to
submit the manuscript for publication. BWHHS: The
British Women's Heart and Health Study is supported
by funding from the British Heart Foundation; and the
Department of Health Policy Research Programme
(England). CaPS: The Caerphilly Prospective study
was conducted by the former MRC Epidemiology Unit
(South Wales) and funded by the Medical Research
Council of the United Kingdom. The Department of
Social and Community Medicine, University of Bristol
now maintains the archive. EAS: The Edinburgh
Artery Study is funded by the British Heart
Foundation (Programme Grant RG/98002), with
Metabochip genotyping funded by a project grant
from the Chief Scientist Office of Scotland (Project
Grant CZB/4/672). ELSA: Samples from the English
Longitudinal Study of Ageing DNA Repository
(EDNAR), received support under a grant
(AG1764406S1) awarded by the National Institute on
Ageing (NIA). ELSA was developed by a team of
researchers based at the National Centre for Social
Research, University College London and the
Institute of Fiscal Studies. The data were collected by
the National Centre for Social Research. ET2DS: The
Edinburgh Type 2 Diabetes Study is funded by the
Medical Research Council (Project Grant G0500877);
the Chief Scientist Office of Scotland (Programme
Support Grant CZQ/1/38); Pfizer plc (Unrestricted
Investigator Led Grant); and Diabetes UK (Clinical
Research Fellowship 10/0003985). Research clinics
were held at the Wellcome Trust Clinical Research
Facility and Princess Alexandra Eye Pavilion in
Edinburgh. MRC NSHD: The MRC National Survey
of Health and Development 1946 is funded by the UK
Medical Research Council (MC_UU_12019/1). WHII:
The Whitehall II study is supported by grants from the
Medical Research Council (K013351); British Heart
Foundation (RG/07/008/23674); Stroke Association;
National Heart Lung and Blood Institute (5RO1
HL036310); National Institute on Aging
(5RO1AG13196); Agency for Health Care Policy
Research (HS06516); and the John D. and Catherine
T. MacArthur Foundation Research Networks on
Successful Midlife Development and Socio-economic
Status and Health. CoLaus: The Cohorte
Lausannoise study was supported by research grants
from the Swiss National Science Foundation
(33CSCO-122661); from GlaxoSmithKline; and the
Faculty of Biology and Medicine of Lausanne,
Switzerland. The authors also express their gratitude
to the participants in the Lausanne CoLaus study and
to the investigators who have contributed to the
SNPs in the 22q13.1 locus (~ 86 Kb in size) were associated with Hb, MCH, MCHC and
MCV. This locus contains four genes, however, TMPRSS6 is a primary candidate gene and has
been previously identified as associated with all four RBC traits [2, 3, 5–9, 11–13, 21]. The lead
SNPs associated with these four traits in the present study were all in TMPRSS6: rs877908 for
Hb (P = 1.27×10−8), rs855791 for MCH and MCV (P = 1.57×10−24 and P = 5.40×10−16, respec-
tively), and rs2413450 for MCHC (P = 2.15×10−8).
There was a strong positive correlation between hemoglobin, hematocrit and red blood cell
count as well as between mean corpuscular hemoglobin and mean corpuscular volume
(r> 0.75; S6 Table). All other RBC trait combinations show weak to moderate positive or nega-
tive correlation with each other (S6 Table).
Replication analysis of ABO locus in the CoLaus study
For replication, 47 SNPs were selected in/around the ABO gene. All of these were below the
suggestive threshold for Hb, Hct, and RCC in the meta-analysis, out of which 15 were below
the significance threshold. The CoLaus study had 2848 participants for whom both genotypes
and phenotypes were available. Using a nominal significance cut-off of P< 0.05 for replication,
we confirmed the association between four significant SNPs and Hb, and between 10 signifi-
cant SNPs and Hct (Table 2). Two significant associations of SNPs with RCC were not repli-
cated. Likewise, associations between five SNPs (rs600038, rs651007, rs579459, rs649129 and
rs495828) and Hb and Hct were not replicated. However, CoLaus was previously part of a
Table 1. Study characteristics.
Study N F,
%
Age,
year
T2D,
%
Ever
smoked, %
eGFR, mL/
min/1.73m2
Hb, g/
dL
Hct, % MCH, pg MCHC, g/dL MCV, fL RCC,
×1012/L
BRHS 2310 0 68.89
(5.62)
12 73 63.13 (11.15) 14.56
(1.21)
45.09
(3.49)
30.13
(1.89)
32.33 (1.16) 93.23
(5.36)
4.84
(0.41)
BWHHS 1884 100 70.73
(5.31)
15 47 66.81 (11.53) 13.45
(1.07)
41.70
(3.20)
29.51
(1.79)
32.30 (1.19)b 91.40
(5.05)
4.57
(0.38)
CaPS 1268 0 56.78
(4.46)
12 80 69.32 (11.93) 14.94
(1.07)
44.65
(3.17)
30.88
(1.83)
33.50 (0.81) b 92.16
(4.78)
4.85
(0.36)
ELSA 1881 47 73.69
(9.45)
14 67 14.25
(1.50)
ET2DS 996 49 67.89
(4.24)
100 61 70.42 (19.03) 14.06
(1.49)
40.62
(4.18)
31.31
(1.96) b
34.61 (0.67) b 90.43
(4.87)
4.50
(0.48)
MRC
NSHD
1672 52 63.29
(1.11)
8a 70 a 92.96 (22.19) 14.21
(1.22)
41.87
(3.41)
30.63
(1.73)
34.11 (1.15)
/33.95 (1.13) b
90.26
(4.72)
4.65
(0.41)
WHII 1082 22 43.78
(5.87)
14.60
(1.16)
Total N 11
093
- - - - - 11 093 8127 8125 b 8125 b 5817 8128
Data are mean (SD). The seven studies included in the analysis are: British Regional Heart Study (BRHS), British Women’s Heart and Health Study
(BWHHS), Caerphilly Prospective Study (CaPS), English Longitudinal Study of Ageing (ELSA), Edinburgh Type 2 Diabetes Study (ET2DS), MRC National
Survey of Health and Development (MRC NSHD) and the Whitehall II Study (WHII). Study characteristics are given for: number of participants with at
least one red blood cell trait available (N), percentage of females in the study (F), participants’ mean age (Age), percentage of participants with conﬁrmed
type 2 diabetes (T2D), percentage of people who currently smoke or have previously smoked (Ever smoked), estimated glomerular ﬁltration rate (eGFR),
hemoglobin (Hb), hematocrit (Hct), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular
volume (MCV) and red blood cell count (RCC).
a Data from a different data collection wave conducted between six to nine years before.
b Calculated traits are shown in red; the MRC NSHD results shown as “b” include 419 participants for whom an observed MCHC value was not available,
instead it was calculated.
doi:10.1371/journal.pone.0156914.t001
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recruitment, in particular the research nurses of
CoLaus: Yolande Barreau, Anne-Lise Bastian, Binasa
Ramic, Martine Moranville, Martine Baumer, Marcy
Sagette, Jeanne Ecoffey, Sylvie Mermoud. CP is
funded by the Wellcome Trust (grant 097451/Z/11/Z).
The funders had no role in study design, data
collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
larger effort to identify loci associated with RBC traits in 71 861 individuals of European or
South Asian ancestry [13]. Four out of five SNPs were present and highly significant in their
analysis for Hb, Hct and RCC, respectively: rs651007 P = 3.82×10−14, 1.26×10−12 and
1.61×10−14; rs579459 P = 1.35×10−15, 7.59 ×10−14 and 9.25×10−18; rs649129 P = 1.46 ×10−15,
1.54×10−13 and 9.77×10−16; rs495828 P = 1.59 ×10−15, 1.48×10−13 and 1.39×10−15, giving confi-
dence that the association between these SNPs and traits is genuine. For Hct and RCC, 29 and
Table 2. Results of meta-analysis and replication analysis for 15 most significant SNPs in the ABO locus.
Meta-analysis (NHb = 11 093; NHct =
8128; NRCC = 8129)
Replication (N = 2848)
rs# allele chr bp trait β SE P β SE P
rs8176685 d 9 136138765 Hb -0.1328 0.0232 1.08×10–8 -0.1000 0.0543 0.06547
Hct -0.5406 0.0802 1.59×10−11 -0.3278 0.1502 0.02909
RCC -0.0533 0.0095 1.98×10−8 -0.0307 0.0197 0.11930
rs149092047 d 9 136139907 Hb -0.1008 0.0173 5.29×10−9 -0.0782 0.0365 0.03198
Hct -0.3519 0.0588 2.22×10−9 -0.2480 0.1009 0.01396
rs2519093 t 9 136141870 Hb -0.1217 0.0193 2.67×10−10 -0.0754 0.0406 0.06335
Hct -0.4398 0.0655 1.83×10−11 -0.2561 0.1123 0.02261
rs28850884 d 9 136145424 Hb -0.1035 0.0178 6.26×10−9 -0.0963 0.0418 0.02129
Hct -0.3576 0.061 4.52×10−9 -0.2965 0.1158 0.01041
rs9411378 a 9 136145425 Hb -0.1033 0.0178 6.47×10−9 -0.0962 0.0417 0.02120
Hct -0.3576 0.0609 4.22×10−9 -0.2952 0.1155 0.01058
rs550057 t 9 136146597 Hb -0.0982 0.0172 1.12×10−8 -0.0793 0.0361 0.02795
Hct -0.3454 0.0585 3.57×10−9 -0.2490 0.0998 0.01257
rs507666 a 9 136149399 Hb -0.1228 0.0193 1.84×10−10 -0.0716 0.0399 0.07251
Hct -0.4441 0.0655 1.19×10−11 -0.2465 0.1104 0.02554
rs8176643 d 9 136149709 Hb -0.1253 0.0199 3.37×10−10 -0.0802 0.0442 0.06930
Hct -0.4607 0.0676 9.64×10−12 -0.2682 0.1222 0.02818
RCC -0.0436 0.008 4.98×10−8 -0.0255 0.0160 0.11180
rs532436 a 9 136149830 Hb -0.1219 0.0193 2.44×10−10 -0.0717 0.0399 0.07242
Hct -0.4418 0.0654 1.47×10−11 -0.2464 0.1104 0.02557
rs600038 c 9 136151806 Hb -0.1021 0.0185 3.47×10−8 -0.0320 0.0381 0.40180
Hct -0.3797 0.0628 1.46×10−9 -0.1355 0.1055 0.19920
rs651007a t 9 136153875 Hb -0.1046 0.0185 1.62×10−8 -0.0329 0.0380 0.38610
Hct -0.3821 0.0628 1.15×10−9 -0.1393 0.1051 0.18500
rs579459a c 9 136154168 Hb -0.1045 0.0185 1.63×10−8 -0.0326 0.0382 0.39290
Hct -0.3820 0.0628 1.16×10−9 -0.1376 0.1056 0.19250
rs649129a t 9 136154304 Hb -0.1053 0.0185 1.29×10−8 -0.0324 0.0382 0.39550
Hct -0.3822 0.0628 1.14×10−9 -0.1372 0.1056 0.19390
rs495828a t 9 136154867 Hb -0.1051 0.0185 1.37×10−8 -0.0324 0.0382 0.39660
Hct -0.3821 0.0628 1.17×10−9 -0.1372 0.1056 0.19400
rs635634 t 9 136155000 Hb -0.1205 0.0193 3.86×10−10 -0.0722 0.0399 0.07080
Hct -0.4393 0.0654 1.90×10−11 -0.2498 0.1105 0.02375
All SNPs were signiﬁcantly associated (P < 5×10−8) with one or more red blood cell traits in seven studies from the UCLEB consortium. For every SNP
(rs#) minor (risk) allele, chromosome (chr) and position (bp) on the human genome build 19 are given. Effect size (β), corresponding standard error (SE)
and P value are shown for each trait associated with the SNP. For replication analysis, SNPs meeting nominal signiﬁcance cut-off of P < 0.05 are marked
in bold.
a Four SNPs previously reported as associated with RBC traits.
doi:10.1371/journal.pone.0156914.t002
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two suggestive associations, respectively, were also replicated. We used the same nominal sig-
nificance cut-off of P< 0.05 to call these associations replicated as they were in a locus already
known to be associated with the traits (S4 Table).
Conditional analyses in HFE locus
Conditional analyses were performed using the two major HFEmutations (C282Y and H63D)
as covariates, to test if the signal in this locus was due to HFE alone. C282Y and H63D lie on
different ancestral haplotypes, which in case of C282Y may extend over 6 Mb and to around
700 kb or less for H63D [22–24]. The strong peak in this region, containing many SNPs, could
be due to the association ofHFEmutations, particularly C282Y, with long founder haplotypes.
For all three traits, the signal in this locus disappeared in conditional analysis, indicating that
these two mutations ofHFE are responsible for all of the observed significant association (S5
Fig). For Hb however, a suggestive signal (spanning ~480 Kb and containing 28 genes) was
seen in the main analysis within the major histocompatibility complex locus at 6p21.32-
6p21.31, centromeric to HFE. This locus remained at the suggestive significance threshold in
the conditional analysis (lead SNP rs2734573, P = 1.33×10−6; S5 Fig).
Conditional analyses in ABO locus
Conditioning on blood groups. At the ABO locus, using Hb as an example, analysis con-
ditional on O blood group haplotype caused the signal at ~135.154 Mb (with rs507666 as lead
SNP) to drop under the suggestive threshold while some SNPs at ~136.131 Mb and proximal
became significant at the suggestive level (Fig 1B) compared to the unconditional analysis. Sim-
ilarly, conditioning on AO blood group haplotype caused the same signal at ~135.154 Mb to
drop around and below the suggestive threshold (Fig 1C). Analyses conditional on AA and B
blood group haplotypes did not differ from the unconditional analysis (Fig 1D and 1E), while
in analysis conditional on AB blood group haplotype a group of SNPs directly proximal to
rs507666 increased in significance (Fig 1F). However, just as in the unconditional analysis,
only three SNPs from this group were above the significance threshold: rs28850884, rs9411378
and rs550057. Analyses run separately on BO and BB blood group haplotypes did not differ
from those in unconditional analysis and so were combined. The distribution of the three traits
Fig 1. Meta-analysis association results for hemoglobin in unconditional and conditional analyses in
the ABO locus.Regional plots show (A) unconditional analysis and analysis conditional on (B) O, (C) AO,
(D) AA, (E) B and (F) AB blood group haplotype. The most significant SNP in the unconditional analysis,
rs507666, is highlighted throughout to facilitate comparison of results. The color coding of the LD between the
SNPs ranges from dark blue for r2 = 0–0.2 to red for r2 = 0.8–1, and is grey where LD information was not
available. Blue line represents suggestive and red line significant threshold.
doi:10.1371/journal.pone.0156914.g001
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associated with the ABO locus according to blood groups is shown in Table 3, with each trait
showing highly significant (p 0.0001) variation across the blood groups.
Conditioning on associated RBC traits. In analyses conditional on RBC traits we expect
to see reduction in the association signal if the trait we are conditioning on plays a role in the
association. Conditional analyses of all three traits, taking each one in turn as the dependent
variable with the other two as covariates, showed total loss of signal at the ABO locus (Fig 2).
When conditioned on Hct, the signal for Hb at the HFE locus disappeared (Fig 2A). However,
when the analysis was conditional on RCC, the signals for Hb and Hct at bothHFE and
TMPRSS6 loci rose (Fig 2B and 2D). The same happened when the analysis for RCC was condi-
tional on Hb and Hct, with bothHFE and TMPRSS6 loci becoming significant (Fig 2E and 2F).
The signal at theHBS1L locus remained unaffected by conditional analyses (Fig 2E and 2F).
Association of ABO SNPs with other cardiometabolic traits
Due to the richly phenotyped studies within the UCLEB consortium we were able to access the
results of prior large scale meta-analyses of a large number of ‘intermediate’ continuous traits,
Table 3. One-way analysis of variance in hemoglobin (Hb), hematocrit (Hct) and red blood cell count (RCC) between different blood groups, as
derived based on three SNP haplotypes.
Blood group NHb Hb Nhct & RCC Hct RCC
AA 890 14.18 (1.26) 659 42.76 (3.77) 4.68 (0.43)
AO 4113 14.19 (1.35) 3007 42.80 (3.86) 4.67 (0.43)
AB 394 14.29 (1.33) 282 42.95 (3.95) 4.70 (0.46)
O 4704 14.33 (1.32) 3434 43.23 (3.86) 4.71 (0.42)
B 992 14.34 (1.34) 746 43.22 (3.88) 4.75 (0.44)
P 4.97×10−06 4.99×10−05 0.0001
Data are number of participants in each group (N) and mean (SD) for each trait. All differences between the groups were highly signiﬁcant (p 0.0001, in
bold). Blood groups are ordered by the increasing value of Hb.
doi:10.1371/journal.pone.0156914.t003
Fig 2. Manhattan plots of meta-analysis association results in unconditional and conditional analyses
for hemoglobin (Hb), hematocrit (Hct) and red blood cell count (RCC).Results show unconditional
analysis for all three traits (top row) and analysis of Hb conditional on (A) Hct and (B) RCC, of Hct conditional
on (C) Hb and (D) RCC and of RCC conditional on (E) Hb and (F) Hct. Line at–log10(P value) = 5.3 represents
suggestive threshold and line at–log10(P value) = 7.3 significant threshold.
doi:10.1371/journal.pone.0156914.g002
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predominantly cardiometabolic traits, including lipids/lipoproteins, coagulation factors and
demographic factors [25]. We identified five cardiometabolic traits that were significantly asso-
ciated with the ABO locus (S7 Fig): factor VIII (FVIII), vonWillebrand factor (log transformed,
logVWF), low-density lipoprotein cholesterol (LDL), total cholesterol (TC), and alkaline phos-
phatase (log transformed, logALP), all of which have been previously reported to be associated
with ABO SNPs [26–32]. The study characteristics for these traits are given in S5 Table. We
directly compared the effect sizes of 15 RBC-associated ABO SNPs across the three RBC and
five additional cardiometabolic traits in the UCLEB consortium dataset using standardized
regression coefficients (β; Fig 3). Direct comparison showed variation in effect size from β =
-0.30 for logALP on rs507666 to β = 0.52 on the same SNP for logVWF, and from β = -0.25 to
β = 0.47 on the widely cited rs651007. The direction of the minor allele effects on RBC traits
and logALP were negative for all SNPs while the same alleles had positive effects on LDL- and
total-cholesterol and coagulation factors, most notably logVWF. Only FVIII showed weak cor-
relation with some of the RBC traits, all other traits were not correlated with RBC traits.
Discussion
Seven studies in the UCLEB Consortium with a total of 11 093 individuals of European ances-
try contributed data for this meta-analysis of six red blood cell traits. There were 394 non-over-
lapping SNPs in five loci associated with the RBC traits at genome-wide significance level, out
of which 86% were significantly associated with more than one trait. The five loci (with candi-
date gene) identified were: 6p22.1-6p21.33 (HFE), 6q23.2 (HBS1L), 6q23.3 (contains no genes),
9q34.3 (ABO) and 22q13.1 (TMPRSS6). Associations at the HFE,HBS1L and TMPRSS6 genes
with RBC traits are well established across different ethnic groups, adults and/or children and
associated with one or more red blood cell traits [2–4, 6–10, 12, 13, 21, 33]. BothHFE and
TMPRSS6 are involved in iron homeostasis by regulating the production of hepcidin, which is
considered to be the “master” iron regulator; mutations in HFE cause the most common form
of hereditary hemochromatosis while mutations in TMPRSS6 cause iron-refractory iron defi-
ciency anemia (IRIDA). SNPs in the HBS1L-MYB locus are associated with fetal hemoglobin
levels and all hematological traits of the three major blood-cell lineages: white blood cells, RBC
Fig 3. Comparison of the effect sizes on 15 ABO SNPs between eight different traits. Traits include von
Willebrand factor (log transformed, logVWF) and factor VIII (FVIII) for coagulation factors, total cholesterol
(TC) and low-density lipoprotein (LDL) for lipids, hemoglobin (Hb), red blood cell count (RCC) and hematocrit
(Hct) for the red blood cell (RBC) traits and alkaline phosphatase (log transformed, logALP) for liver marker
group. The colored bar for each SNP represents the 95% confidence interval of the effect size.
doi:10.1371/journal.pone.0156914.g003
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and platelets. SNPs in the 6q23.3 locus show association with MCH and MCV in several stud-
ies. This locus does not contain any genes itself, however, the nearby CITED2 gene has been
reported as a candidate gene [6, 7, 9, 13]. CITED2 inhibits transactivation of hypoxia-inducible
factor 1-alpha (HIF1A)-induced genes affecting essential physiological processes, including
iron homeostasis. Underlying correlation between the traits is reflected in the results. High cor-
relation between Hb, Hct and RCC shows in the association of these traits with ABO locus,
while high correlation between MCH and MCV shows at almost all other associated loci. Simi-
lar patterns were observed in the CHARGE Consortium [6], where it was suggested that the
observed patterns characterize various clinical hematological diseases and provide context for
interpretation of the results.
We have also replicated and confirmed the association of ABO SNPs with Hb, Hct and RCC
in Europeans, previously reported in East Asians, Caucasians and African-Americans [5, 7, 9,
10, 13, 34]. By imputation to 1000 Genomes data, we identified 11 new SNPs significantly asso-
ciated with these traits and replicated all but one in an independent population, further refining
the associations. We then focused on the characterization of the ABO locus, looking to dissect
its association with RBC traits by means of conditional analysis. First we investigated whether
these three RBC traits were associated with the identified loci, especially ABO, independently.
The results indicated that the signals atHFE and TMPRSS6 were mediated through the MCV
component of Hct and through Hb. This is in agreement with findings that patients with
hereditary hemochromatosis have higher mean Hb and MCV, and lower mean RCC than con-
trols [35, 36], while in iron-deficiency states such as IRIDA, low values for Hb and MCV occur,
with RCC being higher [2, 37]. In both conditions, changes in Hb and MCV are in the opposite
direction to RCC, consistent with our observations in the conditional analysis. TheHBS1L sig-
nal for RCC appeared not to be influenced by Hb or Hct, while the signal at the ABO locus was
influenced by all three traits. Consistent with this association of ABO with RBC traits, a recent
study of biomarkers of iron status found that the ABO locus was associated with serum ferritin
concentration, an indicator of body iron stores, in Europeans [38]. A study conducted in South
Eastern Nigeria found a significant difference in serum iron concentration and total iron bind-
ing capacity (TIBC) between the ABO blood groups, with group A having highest and group O
the lowest values for both iron parameters [39]. Given that the other four loci we identified are
well accepted as having a direct or indirect role in iron homeostasis, it is an intriguing possibil-
ity that the ABO locus may also influence RBC traits through an effect on iron.
Further, we looked at the distribution of the traits associated with the ABO locus in our
study according to haplotypes predicting blood group, which showed a significant difference in
trait means between the blood group types. Results from analyses conditional on the genetic
determinants of blood groups suggested that the locus at ~135.154 Mb is greatly influenced by
the blood group O deletion. They also indicated the possibility of two loci here: one at the 50
end at ~135.15 Mb with rs507666 as the lead SNP, and another one proximal, between ~135.15
and ~135.14 Mb, with rs28850884 as lead SNP. However, these two loci are not entirely inde-
pendent–SNPs in both loci are in moderate LD with each other and the signal on both of them
disappears completely in analysis conditional on rs507666 (results not shown). Since the ABO
locus is also associated with several other traits and diseases, including lipids, coagulation fac-
tors, markers of endothelial function, cardiovascular disease, infectious disease and cancer [26–
32, 40–42], we investigated whether other traits available in the UCLEB Consortium are associ-
ated with it. This directly demonstrated the pleiotropic associations of the same ABO SNPs
with other cardiometabolic traits: coagulation factors (FVIII, logVWF), lipids (LDL, TC) and a
liver function trait (logALP). This is not surprising given that, in addition to their expression
on red blood cells, ABO antigens are widely expressed on different cell types, including vascular
endothelium and epithelium [42, 43]. Hence they have potential for wide influence upon
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human traits. ABO determinants are also present in body fluids and are carried on the coagula-
tion protein vonWillebrand factor, consistent with the ABO locus associations we demon-
strated with these traits [44]. The direction of effect on the ABO alleles associated with
cardiometabolic traits in our study were consistent with previous reports. For different traits,
these effect directions are widely reported to be associated with generally either beneficial or
detrimental effects upon cardiometabolic risk. Our results show that for the 15 ABO SNPs
most strongly associated with RBC traits, an increase in copies of the minor allele was associ-
ated with increased coagulation factor and lipid levels and decreased RBC traits and alkaline
phosphatase. This effect was reversed for blood group O, resulting in decreased coagulation
factor and lipid levels and increased Hb, Hct, RCC and ALP, both acting protective. These find-
ings add to the mounting evidence for the role of the ABO blood group as a risk factor for
development of cardiovascular disease, thrombosis, diabetes mellitus and cancer, with the O
blood type being protective [45–49].
Studies such as ARIC [50] and HEIRS [51] showed thatHFE C282Y homozygosity, which is
associated with increased iron absorption, is also associated with lower total and LDL choles-
terol. Equally, studies show that triglyceride, total cholesterol and LDL cholesterol are
decreased in women with iron deficiency anemia [52, 53]. Both conditions have in common
the diminished production of hepcidin, which in turn leads to iron-depleted macrophages
which may negatively regulate systemic cholesterol levels and so offer protection from athero-
sclerosis [54]. Evidence from mouse studies suggests that macrophage iron depletion may have
pro-inflammatory effects [55]; reviewed in [56], which could be relevant to O blood group indi-
viduals as discussed above. rs651007, close to the 50 end of the ABO gene and significantly asso-
ciated with RBC traits in our study, was the only SNP associated with decreased ferritin
concentration and decreased atherosclerosis risk in a recent study of the role of iron and hepci-
din in atherosclerosis [57]. Additionally, increased levels of IL-10 have been found in acute cor-
onary syndrome cases compared to healthy controls, reflecting an underlying inflammatory
state, with levels of IL-10 being higher in blood type O compared to individuals with other
blood types and associated with poor outcome in these patients [58]. They suggested that
inflammation is a more important risk factor in these individuals, while increased coagulation
is more important in non-O blood type [58].
Finally, the current discovery analysis is somewhat biased towards loci already known to be
associated with cardiometabolic disease due to the design of Metabochip [59]. Imputation to
the 1000 Genomes expanded the regions covered by the chip but could not completely fill the
gaps. Analysis based on GWAS coverage imputed to the latest 1000 Genomes phase could dis-
cover new loci associated with these traits. Most of the studies, including ours, focus on classic
ABO blood group phenotypes. The complexity of the ABO blood group system extends to a
number of different subtypes and the way that they may influence the traits and disease devel-
opment requires more detailed investigation. However, we were able to further dissect the asso-
ciation between ABO locus and RBC traits as well as show how the same SNPs influence range
of traits and put it in context of cardiometabolic risk. Our results support the suggestion by
Johansson et al. [58] that the ABO blood group of an individual may determine which risk fac-
tors are more important for them.
Materials and Methods
Studies and phenotypes
The UCL-LSHTM-Edinburgh-Bristol (UCLEB) Consortium has been described in detail in
Shah et al. [25]. Six RBC traits were analyzed: Hb, Hct, MCH, MCHC, MCV and RCC. We cal-
culated missing traits as detailed in S1 Note. The total sample size in seven eligible studies was
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11 093. The Cohorte Lausannoise [60] (CoLaus, N = 2848) study was approached for replica-
tion of the results due to the availability of both genotypes imputed to 1000 Genomes and the
traits of interest. Discovery and replication study design are further explained in S1 Note. All
participants were of European ancestry.
Ethics Statement
Each study of the UCLEB consortium was approved by the appropriate local research ethics
committee and all participants gave written informed consent, with details as follow: 1958BC
—Written consent was obtained from participants for the use of information in medical stud-
ies. The 45-year biomedical survey and genetic studies were approved by the South-East Multi-
Centre Research Ethics Committee (ref: 01/1/44) and the joint UCL/UCLH Committees on the
Ethics of Human Research (Ref: 08/H0714/40); BRHS—The National Research Ethics Service
Committee for London provided ethical approval. Participants provided a written informed
consent for the investigation, which was performed in accordance with the Declaration of Hel-
sinki; BWHHS—Ethics approval was granted for the British Women’s Heart & Health Studies
from the London Multi Centre Research Ethics Committee and 23 Local Research Ethics Com-
mittees (Harrogate: Harrogate Health Care, Shrewsbury: Shropshire Health Authority, Lowes-
toft: Great Yarmouth James Pagent Healthcare NHS Trust, Mansfield: North Nottinghamshire
Health, Southport: North Sefton Research Ethics Committee, Merthyr Tydfil: Awdurdod
Lechyd Bro Taf Health Authority, Guildford: South West Surrey Local Research Ethics Com-
mittee, Burnley: East Lancashire Health Authority, Newcastle-under-Lyme: North Stafford-
shire Health Authority, Exeter: Exeter Research Ethics Committee, Falkirk: Fife Health Board,
Ipswich: East Suffolk Local Research Ethics Committee, Gloucester: Southmead Health Ser-
vices, Carlisle: East Cumbria Local Research Ethics Committee, Dunfermline: Fife Health
Board, Darlington: County Durham Local Research Ethics Committee, Ayr: Fife Health Board,
Grimsby: South Humber Health Authority, Bedford: North Bedfordshire Health Authority,
Wigan: Wigan & Leigh LREC, Scunthorpe: South Humber Health Authority, Hartlepool: Hart-
lepool Local Research Ethics Committee, Bristol: Southmead Health Services). Participants
were asked for written informed consent to review their medical records and for permission to
perform anonymized genetic tests; CaPS—Ethics approval was obtained from the South East
Wales Local Research Ethics Committee, and each subject signed their agreement to be
involved; EAS—Approval for the study was given by the Lothian Health Board ethics commit-
tee and written informed consent was obtained from each subject; ELSA—Ethical approval for
ELSA was given by the National Research Ethics Service and all participants gave written con-
sent; ET2DS—Ethical permission was obtained from the Lothian Medical Research Ethics
Committee. All subjects attended a dedicated research clinic where they gave written informed
consent for participation in the study;MRCNSHD—Ethical approval was obtained from the
Central Manchester Research Ethics Committee (07/H1008/168 and 07/H1008/245) and
North Thames Multi-Centre Research Ethics Committee (MREC 98/1/121). Informed written
consent was obtained from the study members;WHII—In Whitehall II, participants provided
their written informed consent and the National Health Services (NHS), Health Research
Authority, National Research Ethics Service (NRES) Committee London—Harrow approved
the consent procedure.
Blood samples were collected and analyzed using standard methods and assays.
For the replication study, the Institutional Review Board of the Centre Hospitalier Universi-
taire Vaudois (CHUV) in Lausanne and the Cantonal Ethics Committee approved the CoLaus
study protocol and signed informed consent was obtained from participants. Starting in 2009
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all participants were invited for a follow-up visit five years after the initial study, completed in
2012. This follow-up study was approved by the local ethics committee.
Genotypes and imputation
All studies with RBC traits were genotyped using Metabochip and imputed to the 1000
Genomes (Phase1, CEU haplotype set). Genotyping, quality control (QC) procedures and
imputation were performed in each study separately using the same protocol [25]. The exclu-
sion criteria for samples and SNPs consisted of an Illumina GenCall score< 0.15, sample and
SNP rates< 0.95, HWE P value 0.001, replicate discordance, discrepancy in sex, ethnicity
and relatedness checks or against previous genotype data, where available. No MAF cut-off was
applied at this stage. Imputation was done on cleaned genotypes in three phases—chunking, phas-
ing and imputing—using the MACH1 andMinimac software [61, 62] and applying the strategy
described at Minimac:1000 Genomes Imputation Cookbook. The resulting file contained ~4.5 mil-
lion autosomal SNPs (R2> 0.3, MAF> 0.001). The data were collated in posterior probabilities
from genotype dosage, incorporating imputation uncertainty, to be used by the R Package snpStats.
Association and meta-analysis
Based on descriptive statistics and visual inspection (Table 1; S1 Fig), association testing was
done on untransformed data, separately for each study and on each trait. The associations
between genotyped and imputed SNPs and traits were tested by linear regression using an addi-
tive genetic model. Adjustment was made for age, sex and diabetes status, where appropriate.
Analyses were carried out using snpStats. Prior to meta-analysis, SNPs with MAF
frequency< 0.005 were filtered out. Genomic-control inflation factors (λGC) were calculated
and used to correct test statistics from each study for each trait in the meta-analysis. Study-spe-
cific estimates of effect size were combined by fixed effects meta-analysis weighted by inverse
variance using the METAL program. Genomic-control inflation factors were calculated again
after the meta-analysis, but the results were not further corrected. Significance threshold was
set at P< 5×10−8, suggestive at P< 5×10−6. Locus (significant or suggestive) was defined as all
SNPs below the threshold with SNPs located less than 500 kb apart. LocusZoom [63] was used
to display results, using 1000 Genomes Phase 1 CEU haplotype set for linkage disequilibrium
(LD) calculation. The positions of SNPs are given on human genome build 19.
Conditional analyses
Conditional analysis was performed using the SNPs encoding the two majorHFEmutations,
C282Y (rs1800562) and H63D (rs1799945), as covariates to further investigate if the signal at this
locus for Hb, MCH andMCV was due toHFE alone. Also, to further dissect the signal at the
ABO locus, we used analyses conditional on the genetic determinants of blood groups (AA, AO,
B, AB and O) with a blood group entered as a binary variable one at the time (e.g. O vs all other
groups). The three SNP haplotypes used to derive blood groups are presented in Table 4. To
investigate whether the signal in the ABO locus for Hb, Hct and RCC affects a trait independently
of the other two traits, the subset of five studies which had data on all three traits was analyzed.
For a given trait, the other two traits were included in the model as covariates one at a time [64].
Association with other traits within UCLEB
To assess pleiotropy by direct comparison within UCLEB, we ran an association study on stan-
dardized phenotypes (mean = 0, SD = 1). Effect sizes (standardized regression coefficients, β)
were visualized using phenotypicForest 0.2.
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Pearson's r was calculated to assess correlation between all the traits within the study.
URLs
Minimac: 1000 Genomes Imputation Cookbook, http://genome.sph.umich.edu/wiki/
Minimac:_1000_Genomes_Imputation_Cookbook
snpStats, http://www.bioconductor.org/packages/2.10/bioc/html/snpStats.html
METAL, http://www.sph.umich.edu/csg/abecasis/Metal/
phenotypicForest 0.2, http://chrisladroue.com/phorest/
European Genome-phenome Archive, http://www.ebi.ac.uk/ega
Supporting Information
S1 Fig. Histograms for six red blood cell traits. Please note that the hemoglobin values for
WHII were rounded.
(TIF)
S2 Fig. Manhattan plots of meta-analysis association results for red blood cell traits in the
UCLEB consortium. Line at–log10(P value) = 5.3 represents suggestive threshold and line at–
log10(P value) = 7.3 significant threshold.
(TIF)
S3 Fig. Q-Q plots of meta-analysis association results for red blood cell traits in the UCLEB
consortium.
(TIF)
S4 Fig. Venn diagram of overlap between loci above the significance threshold
(P< 5×10−8). Traits include hemoglobin (Hb), hematocrit (Hct), mean corpuscular hemoglo-
bin (MCH), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular volume
(MCV) and red blood cell count (RCC).
(TIF)
S5 Fig. Manhattan plots of meta-analysis association results for Hb, MCH and MCV in
analyses conditional on two majorHFE gene mutations, C282Y and H63D. Line at–log10(P
value) = 5.3 represents suggestive threshold and line at–log10(P value) = 7.3 significant thresh-
old.
(TIF)
S6 Fig. Comparison between van der Harst et al. and our study on overlapping 79 SNPs
within +/- 10Kb from ABO gene. Regional plots for (A-B) Hb, (D-E) Hct and (E-F) RCC
show two loci: (A,C,E) first locus at ~136.154 close to the 50 region of the gene and (B,D,F) sec-
ond locus at ~136.131 Mb, using 1000 genomes (Phase 1, EUR haplotype set) for LD calcula-
tion. Blue line represents suggestive and red line significant threshold.
(TIF)
Table 4. Blood groups derived based on three SNP haplotypes.
Blood Group rs8176719 rs8176746 rs8176747 Frequency in UCLEB
AA G/G C/C G/G 8.0%
AO Del/G C/C G/G 37.3%
BB G/G A/A C/C 0.4%
BO Del/G A/A C/C 8.4%
AB G/G A/C C/G 3.5%
O Del/Del 42.3%
doi:10.1371/journal.pone.0156914.t004
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S7 Fig. Meta-analysis association results for three red blood cell and five cardiometabolic
traits in the ABO locus. Regional plots show association results for (A) von Willebrand factor
(log transformed, logVWF), (B) factor VIII (FVIII), (C) total cholesterol (TC), (D) low-density
lipoprotein (LDL), (E) hemoglobin (Hb), (F) red blood cell count (RCC), (G) hematocrit (Hct)
and (H) alkaline phosphatase (log transformed, logALP).The most significant associations for
logVWF are capped at 1×10−325. The most significant SNP for Hb, rs507666, is highlighted
throughout to facilitate comparison of results. Blue line represents suggestive and red line sig-
nificant threshold.
(TIF)
S1 Note. Supplementary note.
(DOCX)
S2 Note. Data access arrangements.
(DOCX)
S1 Table. Formulae for calculating missing erythrocyte traits.
(DOCX)
S2 Table. Genomic-control inflation factors (λGC) for each study and trait. λGC were recal-
culated for each trait after meta-analysis.
(DOCX)
S3 Table. Meta-analysis results. All SNPs significantly associated with one or more red blood
cell traits (P< 5×10−8) in seven studies from the UCLEB consortium (separate file).
(XLSX)
S4 Table. Results of replication in the CoLaus study. Results for 47 SNPs in/around ABO
gene, which were either significantly or suggestively associated with Hb, Hct and RCC in seven
studies from the UCLEB consortium. The rs numbers of the SNPs which were significantly asso-
ciated with Hb, Hct and/or RCC (P< 5×10−8, N = 15) in the discovery study are highlighted in
bold and the corresponding fields are marked in blue; these are additionally shown in Table 3.
The significant replication results (P< 0.05) are marked in red (separate file).
(XLSX)
S5 Table. Study characteristics on other cardiometabolic traits associated with ABO SNPs
and available in UCLEB.
(DOCX)
S6 Table. Pearson’s r correlation coefficient between six red blood cell traits and five cardi-
ometabolic traits.
(XLSX)
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